CEL-SCI Company Profile (NYSEMKT:CVM)

About CEL-SCI

CEL-SCI logoCEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: CVM
  • CUSIP:
Key Metrics:
  • Previous Close: $0.10
  • 50 Day Moving Average: $0.118
  • 200 Day Moving Average: $0.246
  • 52-Week Range: $190,965,000.00 - $0.06
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.33
  • P/E Growth: 0.000
  • Market Cap: $18.14M
  • Outstanding Shares: 190,965,000
  • Beta: -0.28
Additional Links:
Companies Related to CEL-SCI:

Analyst Ratings

Consensus Ratings for CEL-SCI (NYSEMKT:CVM) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for CEL-SCI (NYSEMKT:CVM)
Show:
DateFirmActionRatingPrice TargetDetails
3/11/2016Dawson JamesReiterated RatingBuyView Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for CEL-SCI (NYSEMKT:CVM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017        
2/9/2017Q116$0.01ViewN/AView Earnings Details
5/6/2016Q2($0.07)ViewN/AView Earnings Details
5/8/2015($0.11)($0.10)ViewN/AView Earnings Details
2/6/2015($0.09)($0.11)ViewN/AView Earnings Details
8/8/2014($0.11)($0.04)ViewN/AView Earnings Details
5/13/2014Q114($0.11)($0.24)$0.02 million$0.07 millionViewN/AView Earnings Details
2/13/2014Q413($0.11)($0.15)$510.39 millionViewN/AView Earnings Details
1/2/2014Q3($0.27)ViewN/AView Earnings Details
8/12/2013Q213($0.01)ViewN/AView Earnings Details
2/8/2013Q1 2013($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CEL-SCI (NYSEMKT:CVM)
Current Year EPS Consensus Estimate: $-0.420 EPS
Next Year EPS Consensus Estimate: $-0.290 EPS

Dividends

Dividend History for CEL-SCI (NYSEMKT:CVM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CEL-SCI (NYSEMKT:CVM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2014Geert R KerstenCEOBuy14,999$0.77$11,549.23View SEC Filing  
12/30/2013Geert R KerstenCEOBuy300,000$0.60$180,000.00View SEC Filing  
10/9/2013Geert R KerstenInsiderBuy8,400$0.79$6,636.00View SEC Filing  
6/19/2013Peter R YoungDirectorBuy25,000$0.24$6,000.00View SEC Filing  
6/14/2013Geert R KerstenInsiderBuy145,120$0.24$34,828.80View SEC Filing  
5/20/2013Geert R KerstenCEOBuy40,000$0.25$10,000.00View SEC Filing  
5/2/2013Geert R KerstenCEOBuy118,700$0.27$32,049.00View SEC Filing  
3/27/2013Peter R YoungDirectorBuy25,000$0.23$5,750.00View SEC Filing  
3/26/2013Geert R KerstenCEOBuy348,125$0.21$73,106.25View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CEL-SCI (NYSEMKT:CVM)
DateHeadline
News IconStock With Volatility Check: CEL-SCI Corporation (NYSEMKT:CVM) - The Oracle Examiner (NYSEMKT:CVM)
oracleexaminer.com - February 26 at 4:17 PM
News IconIn Our Opinion: Trump's tweet is America's real enemy (NYSEMKT:CVM)
latribunadecanarias.com - February 23 at 9:36 PM
News IconTrump's immigration guidance: the return of sensible law enforcement (NYSEMKT:CVM)
latribunadecanarias.com - February 23 at 4:35 PM
News IconCel-Sci Corporation (CVM) Reviewed By Analysts (NYSEMKT:CVM)
hoyentv.com - February 23 at 4:35 PM
4-traders.com logoCEL-SCI CORPORATION (NYSEMKT:CVM) Files An 8-K Entry into a Material Definitive Agreement (NYSEMKT:CVM)
www.4-traders.com - February 22 at 9:01 AM
us.rd.yahoo.com logoCEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference (NYSEMKT:CVM)
us.rd.yahoo.com - February 21 at 5:55 PM
biz.yahoo.com logoCEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (NYSEMKT:CVM)
biz.yahoo.com - February 21 at 5:55 PM
News Icon11 institutional investors are raising stakes in CEL-SCI Corporation ... - Post Analyst (NYSEMKT:CVM)
postanalyst.com - February 19 at 4:15 PM
4-traders.com logoCEL SCI : NEW STORY CEL-SCI Announces $1.0 Million Registered Direct Offering (NYSEMKT:CVM)
www.4-traders.com - February 17 at 3:38 PM
us.rd.yahoo.com logoCEL-SCI Announces $1.0 Million Registered Direct Offering (NYSEMKT:CVM)
us.rd.yahoo.com - February 17 at 3:38 PM
us.rd.yahoo.com logo8:31 am CEL-SCI Corp commences approx. $1.0 mln direct offering of common stock; will issue approximately 10 million registered shares of common stock at a purchase price of $0.10 per share (NYSEMKT:CVM)
us.rd.yahoo.com - February 17 at 3:38 PM
News IconSCI Corporation's (CVM) jumped 24.50% in past week (NYSEMKT:CVM)
eleganthomesinla.com - February 16 at 1:37 PM
News IconSCI Corporation (AMEX:CVM) Stock Technicals at Critical Inflection Point (NYSEMKT:CVM)
mundoaguaysaneamiento.net - February 16 at 1:37 PM
News IconStock Showing Surging Activity: CEL-SCI Corporation (NYSEMKT:CVM) - HugoPress (NYSEMKT:CVM)
hugopress.com - February 14 at 3:58 PM
News IconCEL-SCI Corporation (:CVM) Touching Most Active List Today - Winfield Review (NYSEMKT:CVM)
winfieldreview.com - February 13 at 10:22 PM
News Icon(CVM) Posts Quarterly Earnings Results (NYSEMKT:CVM)
eleganthomesinla.com - February 11 at 3:06 AM
us.rd.yahoo.com logoCEL-SCI Corporation Reports First Quarter Fiscal 2017 Financial Results (NYSEMKT:CVM)
us.rd.yahoo.com - February 10 at 3:06 AM
sg.finance.yahoo.com logoCel-Sci posts 1Q profit (NYSEMKT:CVM)
sg.finance.yahoo.com - February 9 at 10:04 PM
News IconCEL-SCI Corporation (NYSEMKT:CVM) hit its 52 Week low of $0.06 on Dec 30, 2016 - The Newburgh Press (NYSEMKT:CVM)
newburghpress.com - February 8 at 5:01 PM
News IconIs Selling CEL-SCI Corporation (CVM) Here a Winning Strategy? The Stock Formed Bearish Wedge Down Pattern (NYSEMKT:CVM)
randolphguide.com - February 2 at 4:59 PM
News IconStock Sees Needle Move Upward Pre-Market: Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) (NYSEMKT:CVM)
hoyentv.com - January 31 at 5:13 PM
News IconNext Weeks Broker Price Targets For Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) (NYSEMKT:CVM)
viveremilano.biz - January 31 at 5:13 PM
News IconProminent Runners: BlackBerry Limited (NASDAQ:BBRY), CEL-SCI Corporation (NYSEMKT:CVM) - The Newburgh Press (NYSEMKT:CVM)
newburghpress.com - January 30 at 10:32 PM
News IconAre the Technicals Adding up for CEL-SCI Corporation (:CVM) - Prospect Journal (NYSEMKT:CVM)
prospectjournal.com - January 20 at 5:49 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: CEL-SCI Corporation (:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - January 15 at 4:27 PM
News IconCEL-SCI Corporation (NYSEMKT:CVM) Reports Q42016 Fiscal Results - Journal Transcript (NYSEMKT:CVM)
www.journaltranscript.com - January 12 at 10:00 PM
News IconCel-Sci Corporation (AMEX:CVM) showed monthly volitility of 19.17% - The Newburgh Press (NYSEMKT:CVM)
newburghpress.com - January 12 at 10:00 PM
News IconExact Sciences Guides Revenue Up +142% YOY (NYSEMKT:CVM)
www.guerillastocktrading.com - January 12 at 4:59 PM
istreetwire.com logoStocks Alert: KeyCorp (KEY), CEL-SCI Corporation (CVM), Macy's, Inc. (M) - iStreetWire (NYSEMKT:CVM)
istreetwire.com - January 11 at 5:02 PM
News IconInvestor Hub: Looking at Shares of CEL-SCI Corporation (AMEX:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - January 7 at 10:17 PM
News IconROIC in Review for CEL-SCI Corporation (AMEX:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - January 5 at 5:20 PM
News IconROIC in Review for CEL-SCI Corporation (AMEX:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - January 5 at 5:20 PM
News IconOverselling Alert on: CEL-SCI Corporation (NYSEMKT:CVM) - Post Registrar (NYSEMKT:CVM)
postregistrar.com - January 2 at 4:52 PM
News IconIs This Stock Ready to Rumble: CEL-SCI Corporation (:CVM) - Prospect Journal (NYSEMKT:CVM)
prospectjournal.com - December 30 at 5:00 PM
News IconOverselling Stock in the Spotlight: CEL-SCI Corporation (NYSEMKT:CVM) - Post Registrar (NYSEMKT:CVM)
postregistrar.com - December 30 at 5:00 PM
4-traders.com logoCEL SCI : Announces Closing of Public Offereing and Receives Audit Opinion with Going Concern Explanation (NYSEMKT:CVM)
www.4-traders.com - December 30 at 2:58 AM
News IconEquity Review: Looking Closer at Shares of CEL-SCI Corporation (AMEX:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - December 29 at 4:57 PM
News IconNews Bell: CEL-SCI Corporation (NYSEMKT:CVM), The Chemours Company (NYSE:CC) - The Newburgh Press (NYSEMKT:CVM)
newburghpress.com - December 29 at 4:57 PM
News IconCheap Stock Alert on CEL-SCI Corporation (:CVM) - Prospect Journal (NYSEMKT:CVM)
prospectjournal.com - December 27 at 4:50 PM
biz.yahoo.com logoCEL SCI CORP Files SEC form 8-K, Other Events (NYSEMKT:CVM)
biz.yahoo.com - December 22 at 9:47 PM
businesswire.com logoCEL-SCI Announces Closing of Public Offering and Receives Audit ... - Business Wire (press release) (NYSEMKT:CVM)
www.businesswire.com - December 21 at 10:24 PM
News IconCan This Stock Gain Any Traction: CEL-SCI Corporation (:CVM) - Prospect Journal (NYSEMKT:CVM)
prospectjournal.com - December 21 at 10:24 PM
News IconVC Score in Review for CEL-SCI Corporation (AMEX:CVM) - Business Daily Leader (NYSEMKT:CVM)
businessdailyleader.com - December 21 at 10:24 PM
publicnow.com logoNEW STORY CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern Explanation (NYSEMKT:CVM)
www.publicnow.com - December 21 at 5:24 PM
finance.yahoo.com logoCEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern Explanation (NYSEMKT:CVM)
finance.yahoo.com - December 20 at 10:20 PM
News IconInvestor Update: Checking on Shares of CEL-SCI Corporation (AMEX:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - December 16 at 10:04 PM
sg.finance.yahoo.com logoCel-Sci reports 4Q loss (NYSEMKT:CVM)
sg.finance.yahoo.com - December 14 at 10:40 PM
businesswire.com logoCEL-SCI Reports Fiscal 2016 Financial Results and Clinical & Corporate Developments - Business Wire (press release) (NYSEMKT:CVM)
www.businesswire.com - December 14 at 5:38 PM
News IconStocks under Consideration: CEL-SCI Corporation (NYSEMKT:CVM), Target Corp. (NYSE:TGT) - The Newburgh Press (NYSEMKT:CVM)
newburghpress.com - December 14 at 5:38 PM
News IconStock Levels in View for CEL-SCI Corporation (AMEX:CVM) - Wall Street Beacon (NYSEMKT:CVM)
wsbeacon.com - December 14 at 5:38 PM

Social

What is CEL-SCI's stock symbol?

CEL-SCI trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "CVM."

When will CEL-SCI announce their earnings?

CEL-SCI is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.

How do I buy CEL-SCI stock?

Shares of CEL-SCI can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CEL-SCI stock cost?

One share of CEL-SCI stock can currently be purchased for approximately $0.10.


Last Updated on 2/26/2017 by MarketBeat.com Staff